Background: Central airway obstruction (CAO) occurs in patients with primary or metastatic lung malignancy and nonmalignant pulmonary disorders and results in significant adverse effects on respiratory function and quality of life. Objectives: The objective of this study was to assess the effect of therapeutic bronchoscopic interventions on spirometry, dyspnea, quality of life, and survival in patients with CAO. Methods: We prospectively studied patients who underwent therapeutic rigid bronchoscopy for CAO. Spirometry, San Diego Shortness of Breath questionnaire (SOBQ), and SF-36 questionnaire responses were obtained before the procedure and at follow-up 6-8 weeks after the procedure. Results: Fifty-three patients (24 malignant and 29 nonmalignant CAO), who underwent successful rigid bronchoscopic intervention, were enrolled. Airway stent placement and various debulking techniques including mechanical debridement and heat therapy were used. After bronchoscopy, there was a significant increase in forced vital capacity (2.2 ± 0.91 l before, 2.7 ± 0.80 l after, p = 0.009) and forced expiratory volume at 1 s (1.4 ± 0.60 l before, 1.8 ± 0.67 l after, p = 0.002). The SOBQ score improved from 55.8 ± 30.1 before the procedure to 37.9 ± 27.25 after the procedure (p = 0.002). In the SF-36, there was an improvement in almost all domains, with statistically significant improvement seen in several domains. Benefits were seen independent of the etiology of CAO, site of intervention or stent placement. The patients with malignant CAO, in whom airway patency could not be achieved, had a poor survival. Conclusions: Alleviation of CAO with therapeutic rigid bronchoscopy results in improvement in spirometry, shortness of breath, quality of life, and survival.

Keywords:
Central airway obstruction, Therapeutic bronchoscopy, Tracheobronchial stent, Quality of life, Transplantation, lung
1.
Ernst A, Feller-Kopman D, Becker HD, Mehta AC: Central airway obstruction. Am J Respir Crit Care Med 2004;169:1278-1297.
2.
Venuta F, Rendina EA, De Giacomo T, et al: Nd:YAG laser resection of lung cancer invading the airway as a bridge to surgery and palliative treatment. Ann Thorac Surg 2002;74:995-998.
3.
Oviatt PL, Stather DR, Michaud G, Maceachern P, Tremblay A: Exercise capacity, lung function, and quality of life after interventional bronchoscopy. J Thorac Oncol 2011;6:38-42.
4.
Thistlethwaite PA, Yung G, Kemp A, et al: Airway stenoses after lung transplantation: incidence, management, and outcome. J Thorac Cardiovasc Surg 2008;136:1569-1575.
5.
Shofer SL, Wahidi MM, Davis WA, et al: Significance of and risk factors for the development of central airway stenosis after lung transplantation. Am J Transplant 2013;13:383-389.
6.
Castleberry AW, Worni M, Kuchibhatla M, et al: A comparative analysis of bronchial stricture after lung transplantation in recipients with and without early acute rejection. Ann Thorac Surg 2013;96:1008-1017.
7.
Cavaliere S, Venuta F, Foccoli P, Toninelli C, La Face B: Endoscopic treatment of malignant airway obstructions in 2,008 patients. Chest 1996;110:1536-1542.
8.
Bolliger CT, Probst R, Tschopp K, Soler M, Perruchoud AP: Silicone stents in the management of inoperable tracheobronchial stenoses. Indications and limitations. Chest 1993;104:1653-1659.
9.
Dutau H, Toutblanc B, Lamb C, Seijo L: Use of the Dumon Y-stent in the management of malignant disease involving the carina: a retrospective review of 86 patients. Chest 2004;126:951-958.
10.
Wahidi MM, Unroe MA, Adlakha N, Beyea M, Shofer SL: The use of electrocautery as the primary ablation modality for malignant and benign airway obstruction. J Thorac Oncol 2011;6:1516-1520.
11.
Morice RC, Ece T, Ece F, Keus L: Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction. Chest 2001;119:781-787.
12.
Schumann C, Hetzel M, Babiak AJ, et al: Endobronchial tumor debulking with a flexible cryoprobe for immediate treatment of malignant stenosis. J Thorac Cardiovasc Surg 2010;139:997-1000.
13.
Fernandez-Bussy S, Majid A, Caviedes I, Akindipe O, Baz M, Jantz M: Treatment of airway complications following lung transplantation. Arch Bronconeumol 2011;47:128-133.
14.
Sundset A, Lund MB, Hansen G, Bjortuft O, Kongerud J, Geiran OR: Airway complications after lung transplantation: long-term outcome of silicone stenting. Respiration 2012;83:245-252.
15.
Dutau H, Cavailles A, Sakr L, et al: A retrospective study of silicone stent placement for management of anastomotic airway complications in lung transplant recipients: short- and long-term outcomes. J Heart Lung Transplant 2010;29:658-664.
16.
Anile M, Venuta F, Diso D, et al: Treatment of complex airway lesions after lung transplantation with self-expandable nitinol stents: early experience. Transplant Proc 2010;42:1279-1280.
17.
Fernandez-Bussy S, Akindipe O, Kulkarni V, Swafford W, Baz M, Jantz MA: Clinical experience with a new removable tracheobronchial stent in the management of airway complications after lung transplantation. J Heart Lung Transplant 2009;28:683-688.
18.
Neumann K, Sundset A, Espinoza A, Kongerud J, Fosse E: Changes in quality of life, dyspnea scores, and lung function in lung cancer patients with airway obstruction after a therapeutic bronchoscopy. J Bronchology Interv Pulmonol 2013;20:134-139.
19.
Amjadi K, Voduc N, Cruysberghs Y, et al: Impact of interventional bronchoscopy on quality of life in malignant airway obstruction. Respiration 2008;76:421-428.
20.
Vergnon JM, Costes F, Bayon MC, Emonot A: Efficacy of tracheal and bronchial stent placement on respiratory functional tests. Chest 1995;107:741-746.
21.
Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM: Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 1998;113:619-624.
22.
Swigris JJ, Han M, Vij R, et al: The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. Respir Med 2012;106:1447-1455.
23.
Finlen Copeland CA, Vock DM, Pieper K, Mark DB, Palmer SM: Impact of lung transplantation on recipient quality of life: a serial, prospective, multicenter analysis through the first posttransplant year. Chest 2013;143:744-750.
24.
Moller A, Sartipy U: Associations between changes in quality of life and survival after lung cancer surgery. J Thorac Oncol 2012;7:183-187.
25.
Swigris JJ, Brown KK, Behr J, et al: The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 2010;104:296-304.
26.
Ayers ML, Beamis JF Jr: Rigid bronchoscopy in the twenty-first century. Clin Chest Med 2001;22:355-364.
27.
Dumon JF: A dedicated tracheobronchial stent. Chest 1990;97:328-332.
28.
Celli BR, Cote CG, Marin JM, et al: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
29.
Handa H, Huang J, Murgu SD, et al: Assessment of central airway obstruction using impulse oscillometry before and after interventional bronchoscopy. Respir Care 2014;59:231-240.
30.
Ost DE, Ernst A, Grosu HB, et al: Therapeutic bronchoscopy for malignant central airway obstruction: success rates and impact on dyspnea and quality of life. Chest 2014, Epub ahead of print.
31.
Hespanhol V, Magalhaes A, Marques A: Neoplastic severe central airways obstruction, interventional bronchoscopy: a decision-making analysis. J Thorac Cardiovasc Surg 2013;145:926-932.
32.
Murthy SC, Blackstone EH, Gildea TR, et al: Impact of anastomotic airway complications after lung transplantation. Ann Thorac Surg 2007;84:401-409, 409.e1-409.e4.
33.
Van De Wauwer C, Van Raemdonck D, Verleden GM, et al: Risk factors for airway complications within the first year after lung transplantation. Eur J Cardiothorac Surg 2007;31:703-710.
34.
Santacruz JF, Mehta AC: Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc 2009;6:79-93.
35.
Nouraei SA, Mills H, Butler CR, Ghufoor K, Sandhu GS, George PJ: Outcome of treating airway compromise due to bronchial stenosis with intralesional corticosteroids and cutting-balloon bronchoplasty. Otolaryngol Head Neck Surg 2011;145:623-627.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.